Limaprost alfadex

利马前列素α环糊精

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameLimaprost alfadex
Drug Alias NamelimaprostumLimaprost alpha-cyclodextrinlimaprostProrenalOpalmon +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet aggregation inhibitorsProstanoid EP2 receptor antagonists
TargetsProstanoid EP2 receptor
Therapy Area/IndicationsPeripheral Vascular DiseasesThromboangiitis ObliteransSpinal Stenosis +[4] 
Global Approved IndicationsThromboangiitis ObliteransSpinal Stenosis
Approved Indications in ChinaSpinal Stenosis
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOno Pharmaceutical Co LtdBeijing Tide Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPeripheral Vascular DiseasesThromboangiitis ObliteransSpinal Stenosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA02BBC01EAG02AD
Related LinksDrugBankKEGG